Literature DB >> 25820317

Synthesis of 1-C-Glycoside-Linked Lipid II Analogues Toward Bacterial Transglycosylase Inhibition.

Cheng-Kun Lin1, Kuo-Ting Chen, Chia-Ming Hu, Wen-Yi Yun, Wei-Chieh Cheng.   

Abstract

Preparation of Lipid II analogues containing an enzymatically uncleavable 1-C-glycoside linkage between the disaccharide moiety and the pyrophosphate- or pyrophosphonate-lipid moiety is described. The synthesis of a common 1-C-vinyl disaccharide intermediate has been developed that allows easy preparation of both an elongated sugar-phosphate bond and a sugar-phosphonate moiety, which are coupled with the polyprenyl phosphate to give the desired molecules. Inhibition studies show how a subtle structural modification results in dramatically different potency toward bacterial transglycosylase (TGase), and the results identify Lipid II-C-O-PP (IC50 =25 μM) as a potential TGase inhibitor.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; cell cycle; glycolipids; glycosides; inhibitors

Mesh:

Substances:

Year:  2015        PMID: 25820317     DOI: 10.1002/chem.201406629

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Towards new antibiotics targeting bacterial transglycosylase: Synthesis of a Lipid II analog as stable transition-state mimic inhibitor.

Authors:  Xiaolei Wang; Larissa Krasnova; Kevin Binchia Wu; Wei-Shen Wu; Ting-Jen Cheng; Chi-Huey Wong
Journal:  Bioorg Med Chem Lett       Date:  2018-03-15       Impact factor: 2.823

2.  Characterization of the single-subunit oligosaccharyltransferase STT3A from Trypanosoma brucei using synthetic peptides and lipid-linked oligosaccharide analogs.

Authors:  Ana S Ramírez; Jérémy Boilevin; Rasomoy Biswas; Bee Ha Gan; Daniel Janser; Markus Aebi; Tamis Darbre; Jean-Louis Reymond; Kaspar P Locher
Journal:  Glycobiology       Date:  2017-06-01       Impact factor: 4.313

Review 3.  Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New Antibacterials.

Authors:  Eric Sauvage; Mohammed Terrak
Journal:  Antibiotics (Basel)       Date:  2016-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.